Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Multiple Sclerosis, Relapsing-Remitting

In brief

This study will enroll about 66 participants who experienced a relapse of RRMS that steroids did not help. The doctor will put participants into a treatment group. Each person has an equal chance of being in either one of two groups (like flipping a coin). One group will receive a shot of study medicine (called Acthar Gel) under their skin every day for 14 days. The other group will receive a shot every day for 14 days, too, but there is no medicine in it (called placebo).

Key facts

Study ID
NCT03126760
Run by
Mallinckrodt ARD LLC
People needed
35
Starts
2017-05-22
Expected to finish
2020-07-14
Last updated by the study team
2021-07-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.